Trend in biodegradable porous nanomaterials for anticancer drug delivery

Abstract

AbstractIn recent years, biodegradable nanomaterials have exhibited remarkable promise for drug administration to tumors due to their high drug‐loading capacity, biocompatibility, biodegradability, and clearance. This review will discuss and summarize the trends in utilizing biodegradable nanomaterials for anticancer drug delivery, including biodegradable periodic mesoporous organosilicas (BPMOs) and metal–organic frameworks (MOFs). The distinct structure and features of BPMOs and MOFs will be initially evaluated, as well as their use as delivery vehicles for anticancer drug delivery applications. Then, the themes for the development of each material will be utilized to illustrate their drug delivery performance. Finally, the current obstacles and potential for future development as efficient drug delivery systems will be thoroughly reviewed.This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease